This report focuses on the global Post-operative Nausea and Vomiting (PONV) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Post-operative Nausea and Vomiting (PONV) development in United States, Europe and China. PONV in adults include serotonin antagonists; such as, ramosetron, granisetron, palonosetron, ondansetron, dolasetron, and tropisetron, neurokinin-1 (NK-1) receptor antagonists; such as aprepitant, and rolapitant, steroids; such as dexamethasone and methylprednisolone, dopamine antagonists as transdermal scopolamine [TDS] and others; such as butyrophenones as well as antihistamines (dimenhydrinate and meclizine). Postoperative nausea and vomiting is considered a major clinical issue that can diminish a patient?s quality of life Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period. In 2017, the global Post-operative Nausea and Vomiting (PONV) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study Acacia Pharma Roche AG Novartis Ani Pharmaceuticals Camurus Sanofi Helsinn Holding Eisai Corporation Merck GlaxoSmithKline Market segment by Type, the product can be split into Serotonin Antagonists Steroids Dopamine Antagonists NK-1 Receptor Antagonists Others Non-pharmacologic Treatment Market segment by Application, split into Hospital Pharmacies Online Pharmacies Retail Pharmacies and Drug Stores Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Post-operative Nausea and Vomiting (PONV) status, future forecast, growth opportunity, key market and key players. To present the Post-operative Nausea and Vomiting (PONV) development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Post-operative Nausea and Vomiting (PONV) are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Post-operative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (2013-2025) 1.4.2 Serotonin Antagonists 1.4.3 Steroids 1.4.4 Dopamine Antagonists 1.4.5 NK-1 Receptor Antagonists
